Correvio Pharma (CORV)

[81vette]

Index - P/E - EPS (ttm) -0.90 Insider Own 0.80% Shs Outstand 54.93M Perf Week 9.44%
Market Cap 20.44M Forward P/E - EPS next Y -0.45 Insider Trans 0.00% Shs Float 54.20M Perf Month -19.11%
Income -36.70M PEG - EPS next Q -0.12 Inst Own 76.60% Short Float 8.41% Perf Quarter -20.83%
Sales 30.30M P/S 0.67 EPS this Y 29.50% Inst Trans -0.14% Short Ratio 0.63 Perf Half Y -83.39%
Book/sh 0.03 P/B 12.40 EPS next Y 44.30% ROA -60.90% Target Price 1.08 Perf Year -87.64%
Cash/sh 0.32 P/C 1.15 EPS next 5Y 28.00% ROE - 52W Range 0.21 - 3.22 Perf YTD -9.24%
Dividend - P/FCF - EPS past 5Y -26.80% ROI -16.30% 52W High -88.35% Beta 0.10
Dividend % - Quick Ratio 1.30 Sales past 5Y 44.80% Gross Margin 70.80% 52W Low 78.67% ATR 0.07
Employees 173 Current Ratio 1.50 Sales Q/Q -4.30% Oper. Margin -90.20% RSI (14) 52.14 Volatility 9.42% 15.81%
Optionable Yes Debt/Eq 29.33 EPS Q/Q -13.30% Profit Margin - Rel Volume 0.53 Prev Close 0.37
Shortable No LT Debt/Eq 22.07 Earnings Apr 08 BMO Payout - Avg Volume 7.22M Price 0.38
Recom 3.00 SMA20 0.85% SMA50 6.24% SMA200 -73.56% Volume 1,017,097 Change 0.84%